Company Data
Nektar Therapeutics
Ticker
NKTR
Current Price
$70.59 -2.66%
Market Cap
$2.4B
Price Target
Refer to Report
Volume
57.9K
52wk Range
$27.87 - $109
Overview
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.